What is the market capitalization of Liminatus Pharma, Inc.?

Liminatus Pharma, Inc. (LIMN) has a market capitalization of approximately 6,807,937 USD.

Where can I buy LIMN in Canada?

LIMN can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

LIMN

Liminatus Pharma, Inc.

Liminatus Pharma, Inc. (LIMN) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 7 million USD (micro-cap).

Details

Price0.15 USD

Market cap6.81 M USD

Payout ratio0.00%

SectorHealthcare

Websiteliminatuspharma.com

Updated 2h ago

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.